1. Home
  2. JVA vs NXL Comparison

JVA vs NXL Comparison

Compare JVA & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coffee Holding Co. Inc.

JVA

Coffee Holding Co. Inc.

HOLD

Current Price

$3.67

Market Cap

21.0M

ML Signal

HOLD

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

HOLD

Current Price

$0.82

Market Cap

18.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JVA
NXL
Founded
1971
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Medical Specialities
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.0M
18.6M
IPO Year
2005
2022

Fundamental Metrics

Financial Performance
Metric
JVA
NXL
Price
$3.67
$0.82
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
35.5K
117.7K
Earning Date
01-30-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
64.91
N/A
EPS
0.32
N/A
Revenue
$89,748,681.00
$156,931.00
Revenue This Year
N/A
$38.28
Revenue Next Year
N/A
$185.71
P/E Ratio
$11.21
N/A
Revenue Growth
17.92
N/A
52 Week Low
$2.75
$0.70
52 Week High
$9.93
$3.87

Technical Indicators

Market Signals
Indicator
JVA
NXL
Relative Strength Index (RSI) 49.02 32.96
Support Level $3.31 $0.79
Resistance Level $3.74 $1.01
Average True Range (ATR) 0.17 0.05
MACD 0.03 -0.01
Stochastic Oscillator 80.77 13.29

Price Performance

Historical Comparison
JVA
NXL

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: